%0 Journal Article
%T 末期肾病血瘀证患者与动脉硬化的关系<br>The Association between Blood Stasis Syndrome and Arteriosclerosis in Patients with End Stage Renal Disease
%A 朱元锵
%A 李宗谚
%A 王国辉
%A 陈舜鼎
%A 张恒鸿
%J Traditional Chinese Medicine
%P 1-6
%@ 2166-6059
%D 2013
%I Hans Publishing
%R 10.12677/TCM.2013.21001
%X <p>
	<span style=\"font-family:宋体;font-size:10pt;\">探讨末期肾病接受长期血液透析的病患族群</span><span style=\"font-family:宋体;font-size:10pt;\">，</span><span style=\"font-family:宋体;font-size:10pt;\">其血瘀证表现与动脉重塑的关联性。<b>方法：</b></span><span style=\"font-family:'Times New Roman','serif';font-size:10pt;\">69</span><span style=\"font-family:宋体;font-size:10pt;\">位血液透析病患</span><span style=\"font-family:宋体;font-size:10pt;\">，</span><span style=\"font-family:宋体;font-size:10pt;\">分为血瘀证组</span><span style=\"font-family:'Times New Roman','serif';font-size:10pt;\">40</span><span style=\"font-family:宋体;font-size:10pt;\">例及非血瘀证组</span><span style=\"font-family:'Times New Roman','serif';font-size:10pt;\">29</span><span style=\"font-family:宋体;font-size:10pt;\">例</span><span style=\"font-family:宋体;font-size:10pt;\">，</span><span style=\"font-family:宋体;font-size:10pt;\">比较、记录的项目包括心血管疾病病史及其危险因子</span><span style=\"font-family:宋体;font-size:10pt;\">，</span><span style=\"font-family:宋体;font-size:10pt;\">并以脉波传导速度做为动脉硬化的指标、以足踝</span><span style=\"font-family:宋体;font-size:10pt;\">–</span><span style=\"font-family:宋体;font-size:10pt;\">肱动脉血压比做为动脉粥状硬化的指标。<b>结果：</b>在长期血液透析的病患族群</span><span style=\"font-family:宋体;font-size:10pt;\">，</span><span style=\"font-family:宋体;font-size:10pt;\">血瘀证与冠心病</span><span style=\"font-family:'Times New Roman','serif';font-size:10pt;\">(<i>p </i>&lt; 0.0001)</span><span style=\"font-family:宋体;font-size:10pt;\">及糖尿病</span><span style=\"font-family:'Times New Roman','serif';font-size:10pt;\">(<i>p</i> = 0.018)</span><span style=\"font-family:宋体;font-size:10pt;\">有显着相关；血瘀证组平均年龄较高</span><span style=\"font-family:'Times New Roman','serif';font-size:10pt;\">(<i>p </i>= 0.004)</span><span style=\"font-family:宋体;font-size:10pt;\">；血瘀证组较非血瘀证组</span><span style=\"font-family:宋体;font-size:10pt;\">，</span><span style=\"font-family:宋体;font-size:10pt;\">有较高的脉波传导速度</span><span style=\"font-family:'Times New Roman','serif';font-size:10pt;\">(<i>p </i>&lt; 0.0001)</span><span style=\"font-family:宋体;font-size:10pt;\">、收缩压</span><span style=\"font-family:'Times New Roman','serif';font-size:10pt;\">(<i>p </i>= 0.019)</span><span style=\"font-family:宋体;font-size:10pt;\">及脉搏压</span><span style=\"font-family:'Times New Roman','serif';font-size:10pt;\">(<i>p </i>= 0.004)</span><span style=\"font-family:宋体;font-size:10pt;\">；而在其它心血管疾病危险因子</span><span style=\"font-family:宋体;font-size:10pt;\">，</span><span style=\"font-family:宋体;font-size:10pt;\">两组无显着差异。进一步以</span><span style=\"font-family:'Times New Roman','serif';font-size:10pt;\">logistic</span><span
%K 血瘀证；血液透析；动脉重塑；脉波传导速度<br>Blood Stasis Syndrome
%K Hemodialysis
%K Arterial Remodeling
%K Brachial Ankle Pulse Wave Velocity
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=9447